Your browser doesn't support javascript.
loading
Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma.
Murakami, Satsuki; Ri, Masaki; Ito, Masato; Nakamura, Nobuhiko; Kasahara, Senji; Kitagawa, Junichi; Inagaki, Yuichiro; Kuroda, Junya; Yoshimitsu, Makoto; Okamoto, Akinao; Fukuhara, Noriko; Taji, Hirofumi; Iida, Hiroatsu; Nagai, Hirokazu; Hanamura, Ichiro; Tsujimura, Hideki; Okura, Miyuki; Kurata, Mio; Kuwatsuka, Yachiyo; Atsuta, Yoshiko; Iida, Shinsuke.
Afiliação
  • Murakami S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.
  • Ri M; Department of Hematology, Aichi Medical University, Nagakute, Japan.
  • Ito M; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan. rrmasaki@ybb.ne.jp.
  • Nakamura N; Department of Hematology, Daido Hospital, Nagoya, Japan.
  • Kasahara S; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.
  • Kitagawa J; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan.
  • Inagaki Y; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.
  • Kuroda J; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan.
  • Yoshimitsu M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
  • Okamoto A; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Fukuhara N; Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan.
  • Taji H; Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan.
  • Iida H; Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Nagai H; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Hanamura I; Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Tsujimura H; Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Okura M; Department of Hematology, Aichi Medical University, Nagakute, Japan.
  • Kurata M; Division of Hematology Oncology, Chiba Cancer Center, Chiba, Japan.
  • Kuwatsuka Y; Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
  • Iida S; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
Int J Hematol ; 116(4): 563-569, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35699890
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Diagnostic_studies Limite: Aged / Humans País/Região como assunto: Asia Idioma: En Revista: Int J Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Diagnostic_studies Limite: Aged / Humans País/Região como assunto: Asia Idioma: En Revista: Int J Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão